MedPath

etwork meta-analysis of first-line treatment for ALK-positive NSCLC

Not Applicable
Conditions
ALK-positive NSCLC
Registration Number
JPRN-UMIN000042744
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OS
Secondary Outcome Measures
NameTimeMethod
PFS, ORR, AE(>g3), TRD
© Copyright 2025. All Rights Reserved by MedPath